Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Block of SPG in Chronic Rhinosinusitis With Nasal Polyps
NCT02784262Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Oct 2016
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Norwegian University of Science and Technology. Started Oct 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT02784262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784262.